age limit for semaglutide Weight Loss: How It Works, Comparisons, and More How young is too young

You book directly with your chosen physician and pay up front for the consultation

Monitoring Your Progress with InBody To maximize the benefits of Semaglutide with BPC 157, its essential to track your progress accurately

Significantly more on Wegovy

Choose Semaglutide If: You want the medication with the longer real-world safety record and more accumulated clinical data You've had previous GI sensitivity to medications and want to start with the option that may be slightly better tolerated You have a strong cardiovascular history and your provider wants the extensive SUSTAIN cardiovascular outcomes data behind your treatment You've already tried semaglutide and responded well there's no reason to switch what's working Choose Tirzepatide If: You want the medication with the strongest average weight loss outcomes in clinical trials You have significant insulin resistance or type 2 diabetes where the dual GIP/GLP-1 mechanism provides added metabolic benefit You've plateaued on semaglutide and want to try the additional GIP pathway You're comfortable with a newer medication that has a rapidly growing and compelling safety and efficacy record Not Sure Which Is Right for You

It has been licensed for aiding weight loss in non-diabetic people under the trade name Wegovy, strictly indicated for patients with obesity or overweight with diagnosed weight-related comorbidities [6, 7]

This was maintained until the end of the 12-month follow-up period